Companies Dominating the Breast Biopsy Landscape
- Hologic, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Danaher Corporation
- BD (Becton, Dickinson, and Company)
- Cook Medical LLC
- Argon Medical Devices, Inc.
- B. Braun Melsungen AG
- C.R. Bard, Inc.
- Devicor Medical Products, Inc.
- Cardinal Health, Inc.
Browse Key Market Insights with Data Illustration:
In the News
- Hologic Inc, Hologic announced that its subsidiary, Biotheranostics, received a positive coverage determination from Medicare for Its Breast Cancer Index genomic test. The Breast Cancer Index test is used to predict the likelihood of recurrence in early-stage, hormone receptor-positive breast cancer patients.
- BD (Becton, Dickinson, and Company). BD announced the launch of the BO Intevia 1mL two-step disposable autoinjector, which is used for the subcutaneous injection of biological drugs. The device is designed to enhance patient experience and medication adherence by providing a reliable, easy-to-use, and customizable Infection experience. The BD Intevia autoinjector is part of the company's broader portfolio of products for drug delivery and administration.